Gwm Asset Management LTD Grifols Sa Transaction History

Gwm Asset Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$16.62 - $18.94 $611,250 - $696,575	-36,778 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$15.15 - $19.78 $1.46 Million - $1.9 Million	-96,166 Reduced 72.34%	36,778 $636,000
Q4 2020 Feb 16, 2021	SELL	$16.86 - $19.67 $9.96 Million - $11.6 Million	-590,497 Reduced 81.62%	132,944 $2.52 Million
Q3 2020 Nov 13, 2020	BUY	$15.4 - $20.16 $2.91 Million - $3.81 Million	189,021 Added 35.37%	723,441 $12.6 Million
Q2 2020 Aug 18, 2020	BUY	$18.24 - $21.45 $86,822 - $102,102	4,760 Added 0.9%	534,420 $9.83 Million
Q1 2020 Aug 18, 2020	SELL	$16.28 - $25.63 $1.1 Million - $1.73 Million	-67,360 Reduced 11.28%	529,660 $10.6 Million
Q4 2019 Aug 18, 2020	BUY	$19.57 - $23.52 $11.7 Million - $14 Million	597,020 New	597,020 $13.9 Million

147

151M

2.38M

662K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.57B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Gwm Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Gwm Asset Management LTD with notifications on news.